Hjem › Alopecia areata › Maryland
Alopecia areata kliniske forsøg i Maryland
5 studier for Alopecia areata søger deltagere på steder i Maryland.
Officiel studietekst (engelsk)
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Johns Hopkins University, Baltimore
- Dermatology and Skin Cancer Specialists, LLC, Rockville
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Cutaneous Translational Research Program (CTReP), Baltimore
- Johns Hopkins Hospital Investigational Drug Services (IDS) Pharmacy, Baltimore
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07733765Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 12 til 75 · Alle køn · Opdateret 22. jun. 2026 · NCT05398809A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Kindred Hair and Skin Center, Marriottsville
RekruttererFase 3
Alder 6 til 14 · Alle køn · Opdateret 28. apr. 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- U.S. Dermatology Partners - Rockville, Rockville
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 28. jan. 2026 · NCT07133308Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.